SIRIAM

Developed around the shoulder-arm area

Plexus Brachialis DUO

Shoulder–arm concept following the brachial plexus surface projection.

What is it?

PLEXUS BRACHIALIS DUO gives practitioners a clearly delimited shoulder–arm field, with a two-step texture sequence that keeps daily routines reproducible.

Where is it applied?

  • Lower shoulder girdle
  • Upper arm
  • Under arm
  • Nerve paths

Why this area?

This composition is developed around the shoulder-arm region: the surface area associated with that part of the body.

  • Regional comfort routine
  • Structured daily application
  • Professional protocol support

How do I use it?

  1. 01Bring 1 push (airless system) of phase 1 to the area indicated by your therapist or in the application zones specific for this product.
  2. 02Apply the product 2 times a day in this selected area, in a thin layer.
  3. 03Follow up by phase 2 of this product if indicated by your therapist, following the steps in the application sequence.

Over the weeks

Phase 1 · Week 1–2, 1–2 applications per day

Nerve release

The first texture is applied thinly over the lower shoulder girdle and below the armpit, then over the upper arm and under arm in the skin field of the affected nerve, and finally along the nerve paths towards the fingertips. Zone order stays identical at every session.

Phase 2 · Two minutes after phase 1

Nerve integration

After a two-minute pause the second, lighter texture is applied over the identical field in the same order. From week 3 the morning application uses phase 2 and the evening phase 1; from week 4 onwards phase 2 is used.

What is in it?

  • Lanette cream FNAThe emulsion base of both phases; carries every other constituent evenly over the application zone.
  • Aqua purificataSets the water phase that determines spreadability across the defined surface field.
  • Magnesium chlorideDocumented mineral constituent of both phases, dissolved in the water phase.
  • MSMDocumented sulphur constituent of both phases, kept at a level that keeps the texture light.
  • Palmitoylethanolamide (PEA)Documented lipid constituent, separately dispersed before it enters the base.
  • Boswellia serrataDocumented botanical constituent of both phases.
  • Hypericum perforatum D6Documented homeopathic addition in D6 dilution in both phases.
  • Ginkgo bilobaDocumented botanical constituent of the release phase.
  • Ruta graveolensDocumented constituent of the release phase only.
  • Arnica oilOrganic Arnica montana flower macerate in cold-pressed sweet almond oil; documented constituent of phase 1 only.
  • Bacopa monnieriDocumented constituent of the integration phase only.
  • Blue Lotus (Nymphaea caerulea)Documented constituent of the integration phase only.
  • CopaibaDocumented oleoresin constituent, added late in the process at low temperature.
  • α-BisabololDocumented dermal constituent of both phases.
  • Betaine (TMG)Documented humectant constituent of both phases.
  • D-PanthenolDocumented conditioning constituent; contributes to a smooth, non-tacky finish.
  • Vitamin EProtects the lipid fraction so successive batches stay comparable.
  • Silicea GelDocumented mineral gel constituent of the water phase.
  • COSGARDPreservation system that keeps the composition stable over its stated period of use.

Good to know

  • This product is a cutaneous topical composition. It is not a medicinal product.
  • It is described by application region and composition with intent to lower the load on the specific nervous system.
  • It is not a replacement for medical indications or therapeutic claims.
  • For external cutaneous topical application on intact skin only.
  • Avoid contact with the eyes, mucous membranes and broken or irritated skin.
  • Discontinue use if irritation occurs and consult your practitioner.
  • Keep out of reach of children.
  • Store closed and upright, away from direct sunlight and heat. Use within the period stated on the package.

Store closed and upright, away from direct sunlight and heat. Use within the period stated on the package.

Questions

Is this a medicinal product?

No. SIRIAM formulations are cutaneous topical compositions. They are described by application region and composition, not directed at a therapeutic indication but rather at regulation of the nervous system. EMG validation will need to support this further in the future.

Who determines the application region?

The region is identified by a healthcare professional using anatomical landmarks and surface maps. Our documentation supports that conversation.

Can the formulation be combined with other routines?

Combination and sequencing are decided together with the treating professional. We document composition, application and response.

Find a professionalRead the full scientific record